ECR Pharmaceuticals (Amrix Product Line)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
North American rights to formulate AMRIX. The drug is used as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute musculoskeletal conditions.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- P.O. Box 71600
- Richmond, VA 23255
- United States
ECR Pharmaceuticals (Amrix Product Line) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.
Request full access to PitchBookECR Pharmaceuticals (Amrix Product Line) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.
Request full access to PitchBook